Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Sirt1 in cerebral ischemia.

Koronowski KB, Perez-Pinzon MA.

Brain Circ. 2015;1(1):69-78. Epub 2015 Sep 30.

2.

Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP).

Islam BU, Habib S, Ahmad P, Allarakha S, Moinuddin, Ali A.

Indian J Clin Biochem. 2015 Oct;30(4):368-85. doi: 10.1007/s12291-014-0475-8. Epub 2015 Jan 20. Review.

PMID:
26788021
3.

Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.

Turjeman K, Bavli Y, Kizelsztein P, Schilt Y, Allon N, Katzir TB, Sasson E, Raviv U, Ovadia H, Barenholz Y.

PLoS One. 2015 Jul 6;10(7):e0130442. doi: 10.1371/journal.pone.0130442. eCollection 2015.

4.

Humoral factors in ALS patients during disease progression.

Ehrhart J, Smith AJ, Kuzmin-Nichols N, Zesiewicz TA, Jahan I, Shytle RD, Kim SH, Sanberg CD, Vu TH, Gooch CL, Sanberg PR, Garbuzova-Davis S.

J Neuroinflammation. 2015 Jun 28;12:127. doi: 10.1186/s12974-015-0350-4.

5.

ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons.

Lenzi J, De Santis R, de Turris V, Morlando M, Laneve P, Calvo A, Caliendo V, ChiĆ² A, Rosa A, Bozzoni I.

Dis Model Mech. 2015 Jul 1;8(7):755-66. doi: 10.1242/dmm.020099. Epub 2015 Apr 23.

6.

RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.

Bakkar N, Kousari A, Kovalik T, Li Y, Bowser R.

Mol Cell Biol. 2015 Jul;35(14):2385-99. doi: 10.1128/MCB.00087-15. Epub 2015 May 4.

7.

DJ-1 knockout augments disease severity and shortens survival in a mouse model of ALS.

Lev N, Barhum Y, Lotan I, Steiner I, Offen D.

PLoS One. 2015 Mar 30;10(3):e0117190. doi: 10.1371/journal.pone.0117190. eCollection 2015.

8.

NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage.

Xiong W, MacColl Garfinkel AE, Li Y, Benowitz LI, Cepko CL.

J Clin Invest. 2015 Apr;125(4):1433-45. doi: 10.1172/JCI79735. Epub 2015 Mar 23.

9.
10.

The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis.

Tadic V, Prell T, Lautenschlaeger J, Grosskreutz J.

Front Cell Neurosci. 2014 May 30;8:147. doi: 10.3389/fncel.2014.00147. eCollection 2014. Review.

11.

The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis.

Pollari E, Goldsteins G, Bart G, Koistinaho J, Giniatullin R.

Front Cell Neurosci. 2014 May 13;8:131. doi: 10.3389/fncel.2014.00131. eCollection 2014. Review.

12.

Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis.

Tan W, Pasinelli P, Trotti D.

Biochim Biophys Acta. 2014 Aug;1842(8):1295-301. doi: 10.1016/j.bbadis.2014.02.009. Epub 2014 Feb 22. Review.

13.

SIRT1 in neurodevelopment and brain senescence.

Herskovits AZ, Guarente L.

Neuron. 2014 Feb 5;81(3):471-83. doi: 10.1016/j.neuron.2014.01.028. Review.

14.

Antioxidant gene therapy against neuronal cell death.

Navarro-Yepes J, Zavala-Flores L, Anandhan A, Wang F, Skotak M, Chandra N, Li M, Pappa A, Martinez-Fong D, Del Razo LM, Quintanilla-Vega B, Franco R.

Pharmacol Ther. 2014 May;142(2):206-30. doi: 10.1016/j.pharmthera.2013.12.007. Epub 2013 Dec 12. Review.

15.

SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration.

Milani P, Ambrosi G, Gammoh O, Blandini F, Cereda C.

Oxid Med Cell Longev. 2013;2013:836760. doi: 10.1155/2013/836760. Epub 2013 Jul 28. Review.

16.

MST1 functions as a key modulator of neurodegeneration in a mouse model of ALS.

Lee JK, Shin JH, Hwang SG, Gwag BJ, McKee AC, Lee J, Kowall NW, Ryu H, Lim DS, Choi EJ.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12066-71. doi: 10.1073/pnas.1300894110. Epub 2013 Jul 1.

17.

Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis.

Nanou A, Higginbottom A, Valori CF, Wyles M, Ning K, Shaw P, Azzouz M.

Mol Ther. 2013 Aug;21(8):1486-96. doi: 10.1038/mt.2013.115. Epub 2013 Jun 4.

18.

Alzheimer's disease-associated polymorphisms in human OGG1 alter catalytic activity and sensitize cells to DNA damage.

Jacob KD, Noren Hooten N, Tadokoro T, Lohani A, Barnes J, Evans MK.

Free Radic Biol Med. 2013 Oct;63:115-25. doi: 10.1016/j.freeradbiomed.2013.05.010. Epub 2013 May 14.

19.

Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.

Zhang Y, Cook A, Kim J, Baranov SV, Jiang J, Smith K, Cormier K, Bennett E, Browser RP, Day AL, Carlisle DL, Ferrante RJ, Wang X, Friedlander RM.

Neurobiol Dis. 2013 Jul;55:26-35. doi: 10.1016/j.nbd.2013.03.008. Epub 2013 Mar 26.

20.

Redox regulation in amyotrophic lateral sclerosis.

Parakh S, Spencer DM, Halloran MA, Soo KY, Atkin JD.

Oxid Med Cell Longev. 2013;2013:408681. doi: 10.1155/2013/408681. Epub 2013 Feb 25. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk